Skip to main content
LGND logo

Ligand Pharmaceuticals Incorporated

LGNDNASDAQHealthcareBiotechnology

$298.50Today:- (-)1Y +65.13%

As of Oct 15, 2026 close

Market cap
$6.52B
P/E (TTM)
33.05
Forward P/E
-
Dividend yield
-
52-week range
$175.89$326.63
Volume (live)
-
Avg. volume (3M)
254.63K

Ligand Pharmaceuticals Incorporated (LGND) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Ligand Pharmaceuticals Incorporated generated $49.36M of operating cash flow and spent $452.00K on capital expenditures. That left free cash flow of $48.91M, down 48.6% from $95.23M a year earlier, or 18.2% of revenue. It repurchased $137.85M of its own shares.

Ligand Pharmaceuticals Incorporated Cash Flow Statement Analysis

Values in billions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Ligand Pharmaceuticals Incorporated (LGND) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income0.120.000.05-0.030.060.000.630.140.01
Depreciation & Amortization0.030.040.040.050.050.030.040.010.01
Deferred Income Tax0.02-0.020.010.02-0.01-0.020.070.030.04
Stock Based Compensation0.050.040.030.060.040.030.020.020.02
Change in Working Capital-0.010.02-0.030.07-0.06-0.010.00-0.04-0.01
Change in Accounts Receivable-0.02-0.010.000.06-0.03-0.030.03-0.03-0.01
Change in Inventory0.000.01-0.010.010.00-0.020.000.000.00
Change in Accounts Payable0.010.010.000.000.000.00-0.020.000.00
Change in Other Working Capital0.000.000.010.01-0.010.00-0.010.000.00
Other Operating Activities-0.140.010.010.01-0.01-0.02-0.800.020.01
Net Cash from Operating Activities0.050.100.050.140.080.05-0.030.190.09
Investing Activities
Capital Expenditures0.000.00-0.05-0.02-0.010.000.00-0.01-0.01
Acquisitions-0.01-0.17-0.030.000.00-0.40-0.01-0.01-0.03
Purchases of Investments-0.74-0.23-0.13-0.05-0.180.62-2.36-1.43-0.25
Sales/Maturities of Investments0.380.260.190.230.220.002.031.020.20
Other Investing Activities-0.01-0.01-0.050.000.000.000.810.000.01
Net Cash from Investing Activities-0.38-0.14-0.010.160.030.230.47-0.42-0.08
Financing Activities
Debt Repayment-0.110.00-0.08-0.26-0.16-0.23-0.030.530.00
Common Stock Issued0.120.100.000.000.050.000.000.000.00
Common Stock Repurchased-0.14-0.010.00-0.01-0.02-0.08-0.45-0.120.00
Other Financing Activities0.060.00-0.01-0.020.000.000.00-0.08-0.01
Net Cash from Financing Activities0.430.10-0.06-0.28-0.14-0.31-0.490.33-0.01
Summary
Effect of Forex Changes on Cash0.000.000.000.000.000.000.000.000.00
Net Change in Cash0.100.05-0.020.03-0.03-0.02-0.050.100.00
Cash at Beginning of Period0.070.020.050.020.050.070.120.020.02
Cash at End of Period0.170.070.020.050.020.050.070.120.02
Free Cash Flow0.050.100.000.120.070.05-0.030.180.09
Supplemental Disclosures
Interest Paid-0.000.000.000.000.00---
Income Taxes Paid-0.020.010.010.000.00---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Ligand Pharmaceuticals Incorporated Cash Flow

What is Ligand Pharmaceuticals Incorporated's free cash flow?

Ligand Pharmaceuticals Incorporated generated free cash flow of $48.91M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $49.36M minus $452.00K of capital expenditures. That was down 48.6% from $95.23M a year earlier. Free cash flow equaled 18.2% of revenue.

How much does Ligand Pharmaceuticals Incorporated spend on capital expenditures?

Ligand Pharmaceuticals Incorporated spent $452.00K on capital expenditures in fiscal 2025, compared with $1.82M a year earlier. That equals 0.9% of operating cash flow.

Does Ligand Pharmaceuticals Incorporated pay dividends or buy back shares?

Yes. In fiscal 2025 Ligand Pharmaceuticals Incorporated returned $137.85M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition